NL139749B - METHOD OF PREPARING PENICILLINS SUITABLE FOR ORAL ADMINISTRATION, AND METHOD OF PREPARING A THERAPEUTIC AND FORMED THERAPEUTIC PREPARATION. - Google Patents

METHOD OF PREPARING PENICILLINS SUITABLE FOR ORAL ADMINISTRATION, AND METHOD OF PREPARING A THERAPEUTIC AND FORMED THERAPEUTIC PREPARATION.

Info

Publication number
NL139749B
NL139749B NL6907604A NL6907604A NL139749B NL 139749 B NL139749 B NL 139749B NL 6907604 A NL6907604 A NL 6907604A NL 6907604 A NL6907604 A NL 6907604A NL 139749 B NL139749 B NL 139749B
Authority
NL
Netherlands
Prior art keywords
preparing
therapeutic
oral administration
preparation
penicillins suitable
Prior art date
Application number
NL6907604A
Other languages
Dutch (nl)
Other versions
NL6907604A (en
Original Assignee
Laeaeketehdas Orion Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laeaeketehdas Orion Oy filed Critical Laeaeketehdas Orion Oy
Publication of NL6907604A publication Critical patent/NL6907604A/xx
Publication of NL139749B publication Critical patent/NL139749B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D309/06—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL6907604A 1968-05-20 1969-05-19 METHOD OF PREPARING PENICILLINS SUITABLE FOR ORAL ADMINISTRATION, AND METHOD OF PREPARING A THERAPEUTIC AND FORMED THERAPEUTIC PREPARATION. NL139749B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI141368A FI42085B (en) 1968-05-20 1968-05-20

Publications (2)

Publication Number Publication Date
NL6907604A NL6907604A (en) 1969-11-24
NL139749B true NL139749B (en) 1973-09-17

Family

ID=8505597

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6907604A NL139749B (en) 1968-05-20 1969-05-19 METHOD OF PREPARING PENICILLINS SUITABLE FOR ORAL ADMINISTRATION, AND METHOD OF PREPARING A THERAPEUTIC AND FORMED THERAPEUTIC PREPARATION.

Country Status (10)

Country Link
AT (1) AT283598B (en)
BE (1) BE733180A (en)
CH (1) CH518308A (en)
DE (1) DE1924760C3 (en)
ES (1) ES367403A1 (en)
FI (1) FI42085B (en)
FR (1) FR2009922A1 (en)
GB (1) GB1223524A (en)
NL (1) NL139749B (en)
SE (1) SE369526B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788812A (en) * 1971-09-14 1973-03-14 Squibb & Sons Inc THIOACETYLATED PENICILLINS AND CEPHALOSPORINS, THEIR PREPARATION AND THERAPEUTIC USES
GB1506233A (en) * 1974-08-30 1978-04-05 Squibb & Sons Inc Cephalosporin derivatives
US7495050B2 (en) 2000-02-16 2009-02-24 Lubrizol Advanced Materials, Inc. Associative thickeners for aqueous systems
US6596899B1 (en) 2000-02-16 2003-07-22 Noveon Ip Holdings Corp. S,S′BIS-(α, α′-DISUBSTITUTED-α″-ACETIC ACID)- TRITHIOCARBONATES AND DERIVATIVES AS INITIATOR-CHAIN TRANSFER AGENT-TERMINATOR FOR CONTROLLED RADICAL POLYMERIZATIONS AND THE PROCESS FOR MAKING THE SAME
US7335788B2 (en) * 2000-02-16 2008-02-26 Lubrizol Advanced Materials, Inc. S-(α, α′-disubstituted-α″-acetic acid) substituted dithiocarbonate derivatives for controlled radical polymerizations, process and polymers made therefrom
US7557235B2 (en) 2000-02-16 2009-07-07 Lubrizol Advanced Materials, Inc. Hydroxyl-terminated thiocarbonate containing compounds, polymers, and copolymers, and polyurethanes and urethane acrylics made therefrom
US7205368B2 (en) * 2000-02-16 2007-04-17 Noveon, Inc. S-(α, α′-disubstituted-α′ ′-acetic acid) substituted dithiocarbonate derivatives for controlled radical polymerizations, process and polymers made therefrom

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB900666A (en) * 1960-05-13 1962-07-11 Beecham Res Lab Antibacterial agents

Also Published As

Publication number Publication date
GB1223524A (en) 1971-02-24
DE1924760A1 (en) 1969-11-27
DE1924760C3 (en) 1975-04-24
NL6907604A (en) 1969-11-24
DE1924760B2 (en) 1974-09-12
FI42085B (en) 1970-02-02
AT283598B (en) 1970-08-10
CH518308A (en) 1972-01-31
BE733180A (en) 1969-11-03
FR2009922A1 (en) 1970-02-13
ES367403A1 (en) 1971-04-01
SE369526B (en) 1974-09-02

Similar Documents

Publication Publication Date Title
NL182369C (en) METHOD FOR PREPARING AN ORAL EXTENDED MEDICINE PREPARATION
NL172511C (en) METHOD FOR PREPARING OR MANUFACTURING A MEDICINE AGAINST INFLAMMATION
NL7601069A (en) PROCESS FOR PREPARING FOR ORAL ADMINISTRATION.
NL175788C (en) METHOD FOR PREPARING AN ORAL PREPARATION WITH ANTI-INFLAMMATORY AND ANALGETIC ACTION
NL7400393A (en) PROCEDURE FOR PREPARING A DENTAL PREPARATION.
NL170921C (en) METHOD FOR PREPARING MEDICINAL PREPARATIONS FOR A THERAPY OR PROPHYLAXY OF PRECANCEROSES AND CARCINOMAS.
NL164472C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION SUITABLE FOR ORAL ADMINISTRATION, SUITABLE FOR THE TREATMENT OF OESOPHAGITIS AND ARTICLES OBTAINED THEREOF.
NL173643C (en) METHOD FOR MANUFACTURING A PHARMACEUTICAL PREPARATION AND METHOD FOR PREPARING A COMPOUND SUITABLE FOR USE IN THE FOREGOING METHOD
NL143924B (en) METHOD OF PREPARING A MEDICINAL PRODUCT AGAINST HYPERTENSION.
NL161451B (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION AND PROCEDURE FOR PREPARING A COMPOUND, SUITABLE FOR USE IN THE PREPARATION OF THIS PREPARATION.
NL139749B (en) METHOD OF PREPARING PENICILLINS SUITABLE FOR ORAL ADMINISTRATION, AND METHOD OF PREPARING A THERAPEUTIC AND FORMED THERAPEUTIC PREPARATION.
NL147633B (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION, SUITABLE FOR ARRANGING AN ANTIHYPERTENSIVE EFFECT, BY PUTTING A PICOLIC ACID DERIVATIVE INTO A FORM SUITABLE FOR THERAPEUTIC ADMINISTRATION AND PREPARED FORM.
NL170733C (en) METHOD FOR PREPARING OR MANUFACTURING A MEDICINAL PRODUCT AND METHOD FOR PREPARING A MEDICINAL COMPOUND
NL141188B (en) METHOD OF PREPARING A MEDICINAL PRODUCT.
NL178256C (en) A method for preparing a lysergic acid amide or a pharmaceutically acceptable acid addition salt thereof, and a method for preparing a medicament.
NL175292C (en) METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ANALGETIC ACTION, AND A METHOD FOR PREPARING A 2-AMINOTETRALINE DERIVATIVE OR A PHARMACEUTICALLY ACCEPTABLE ACID SALT THEREOF
NL166466C (en) METHOD FOR PREPARING OR MANUFACTURING PHARMACEUTICAL PREPARATIONS WITH AN ANTI-SPLASH AND BRONCHOLYTIC ACTIVITY AND METHOD FOR PREPARING SUITABLE MEDICINAL COMPOUNDS.
NL7312032A (en) METHOD FOR THE PREPARATION AND ADMINISTRATION OF A VETERINARY MEDICINAL PRODUCT.
NL7804470A (en) METHOD FOR PREPARING A CETYLPYRIDINIUM SALT, METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION AND FORMED THERAPEUTIC PREPARATION.
NL144328B (en) METHOD OF PREPARING AN ANTIBIOTIC, AS WELL AS FOR PREPARING A THERAPEUTIC PREPARATION CONTAINING THIS ANTIBIOTIC AND THE PREPARATION PREPARED ITSELF.
NL7610260A (en) METHOD FOR THE PREPARATION OF ACTIVE MEDICINAL PRODUCTS FOR ORAL OR ANAL ADMINISTRATION.
NL180276C (en) METHOD FOR PREPARING OR MANUFACTURING A PREPARATION INTENDED FOR VETERINARY USE
NL163220C (en) PROCESS FOR PREPARING A CO-R COBAMIDE, AND PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION CONTAINING PREPARED CO-R-COBAMIDE
NL160276C (en) PROCESS FOR THE PREPARATION OF STAGE ACTIVE 3-OXO-13BETA-ALKYL-17BETA-ACETYL-17ALFA-HYDROXY-DELTA 4-GONEEN OR GONADIENE DERIVATIVES AND PROCESS FOR PREPARING A MEDICINAL PRODUCT.
NL150441B (en) METHOD FOR PREPARING A PHARMACEUTICAL COMPOUND AND A PHARMACEUTICAL PREPARATION.